Veterinary Medicines

Albex Gold 200 mg/ml oral suspension for cattle

Authorised
  • Albendazole
Download as PDF

Product identification

Medicine name:
Albex Gold 200 mg/ml ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Albex Gold 200 mg/ml oral suspension for cattle
Active substance:
  • Albendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Albendazole
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        7
        day
      • Milk
        84
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 70831/26-07-2021/K-0120503
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0637/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Poland

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."